Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice

Virology

Volumn 413, Issue 1, 2011, Pages 84-92

  Tate, Michelle D ^a   Job, Emma R ^a   Brooks, Andrew G ^a   Reading, Patrick C ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Collectin; Influenza; Innate; Mice; Virulence

Indexed keywords

ASPARAGINE; COLLECTIN; INFLUENZA VIRUS HEMAGGLUTININ;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLYCOSYLATION; IMMUNITY; INFECTION SENSITIVITY; INFLUENZA VIRUS A H3N2; MACROPHAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; COLLECTINS; GLYCOSYLATION; HEMAGGLUTININS, VIRAL; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MALE; MICE; MICE, INBRED C57BL; RESPIRATORY SYSTEM; VIRULENCE;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 79953117247     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.01.036     Document Type: Article

References (50)

1. Abe Y., Takashita E., Sugawara K., Matsuzaki Y., Muraki Y., Hongo S. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J. Virol. 2004, 78:9605-9611.
2. Anders E.M., Hartley C.A., Jackson D.C. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl Acad. Sci. USA 1990, 87:4485-4489.
3. Anders E.M., Hartley C.A., Reading P.C., Ezekowitz R.A. Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J. Gen. Virol. 1994, 75(Pt 3):615-622.
4. Cherry, J.L., Lipman, D.J., Nikolskaya, A., Wolf, Y.I., 2009. Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin. PLoS Curr Influenza. RRN1001.
5. Daniels R., Kurowski B., Johnson A.E., Hebert D.N. N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol. Cell 2003, 11:79-90.
6. Eylar E.H., Madoff M.A., Brody O.V., Oncley J.L. The contribution of sialic acid to the surface charge of the erythrocyte. J. Biol. Chem. 1962, 237:1992-2000.
7. Glaser L., Conenello G., Paulson J., Palese P. Effective replication of human influenza viruses in mice lacking a major alpha2, 6 sialyltransferase. Virus Res. 2007, 126:9-18.
8. Hartley C.A., Jackson D.C., Anders E.M. Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin. J. Virol. 1992, 66:4358-4363.
9. Hartley C.A., Reading P.C., Ward A.C., Anders E.M. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch. Virol. 1997, 142:75-88.
10. Hartshorn K.L., Crouch E.C., White M.R., Eggleton P., Tauber A.I., Chang D., Sastry K. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest. 1994, 94:311-319.
11. Hartshorn K.L., Webby R., White M.R., Tecle T., Pan C., Boucher S., Moreland R.J., Crouch E.C., Scheule R.K. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir. Res. 2008, 9:65.
12. Hartshorn K.L., White M.R., Shepherd V., Reid K., Jensenius J.C., Crouch E.C. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am. J. Physiol. 1997, 273:L1156-L1166.
13. Hartshorn K.L., White M.R., Voelker D.R., Coburn J., Zaner K., Crouch E.C. Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem. J. 2000, 351(Pt 2):449-458.
14. Hedlund M., Tangvoranuntakul P., Takematsu H., Long J.M., Housley G.D., Kozutsumi Y., Suzuki A., Wynshaw-Boris A., Ryan A.F., Gallo R.L., Varki N., Varki A. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol. Cell. Biol. 2007, 27:4340-4346.
15. Hoffmann E., Krauss S., Perez D., Webby R., Webster R.G. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 2002, 20:3165-3170.
16. Igarashi M., Ito K., Kida H., Takada A. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin. Virology 2008, 376:323-329.
17. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997, 227:493-499.
18. Kawaoka Y., Webster R.G. Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin. J. Virol. 1989, 63:3296-3300.
19. Klenk H.D., Wagner R., Heuer D., Wolff T. Importance of hemagglutinin glycosylation for the biological functions of influenza virus. Virus Res. 2002, 82:73-75.
20. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 1985, 54:631-664.
21. Luh S.P., Chiang C.H. Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies. J. Zhejiang Univ. Sci. B 2007, 8:60-69.
22. Makatsori E., Fermani K., Aletras A., Karamanos N.K., Tsegenidis T. Screening of N-acylneuraminic acids in serum and tissue specimens of mouse C57BI with Lewis' lung cancer by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 1998, 712:23-29.
23. Markotic A., Lumen R., Marusic A., Jonjic S., Muthing J. Ganglioside expression in tissues of mice lacking the tumor necrosis factor receptor 1. Carbohydr. Res. 1999, 321:75-87.
24. Medeiros R., Escriou N., Naffakh N., Manuguerra J.C., van der Werf S. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology 2001, 289:74-85.
25. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., Hughes M., Perez D.R., Donis R., Hoffmann E., Hobom G., Kawaoka Y. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 1999, 96:9345-9350.
26. Nicholls J.M., Peiris J.S., Guan Y. Sialic acid and receptor expression on the respiratory tract in normal subjects and H5N1 and non-avian influenza patients. Hong Kong Med. J. 2009, 15:16-20.
27. Ning Z.Y., Luo M.Y., Qi W.B., Yu B., Jiao P.R., Liao M. Detection of expression of influenza virus receptors in tissues of BALB/c mice by histochemistry. Vet. Res. Commun. 2009, 33:895-903.
28. Nobusawa E., Aoyama T., Kato H., Suzuki Y., Tateno Y., Nakajima K. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 1991, 182:475-485.
29. Ohuchi M., Ohuchi R., Feldmann A., Klenk H.D. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J. Virol. 1997, 71:8377-8384.
30. Ohuchi R., Ohuchi M., Garten W., Klenk H.D. Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity. J. Virol. 1997, 71:3719-3725.
31. Reading P.C., Miller J.L., Anders E.M. Involvement of the mannose receptor in infection of macrophages by influenza virus. J. Virol. 2000, 74:5190-5197.
32. Reading P.C., Morey L.S., Crouch E.C., Anders E.M. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 1997, 71:8204-8212.
33. Reading P.C., Pickett D.L., Tate M.D., Whitney P.G., Job E.R., Brooks A.G. Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir. Res. 2009, 10:117.
34. Reading P.C., Whitney P.G., Pickett D.L., Tate M.D., Brooks A.G. Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice. Immunol. Cell Biol. 2010, 88:641-650.
35. Roberts P.C., Garten W., Klenk H.D. Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. J. Virol. 1993, 67:3048-3060.
36. Rogers G.N., Paulson J.C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983, 127:361-373.
37. Seidel W., Kunkel F., Geisler B., Garten W., Herrmann B., Dohner L., Klenk H.D. Intraepidemic variants of influenza virus H3 hemagglutinin differing in the number of carbohydrate side chains. Arch. Virol. 1991, 120:289-296.
38. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
39. Suzuki Y., Matsunaga M., Matsumoto M. N-Acetylneuraminyllactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption-fusion process of viral infection. Binding specificity of influenza virus A/Aichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid. J. Biol. Chem. 1985, 260:1362-1365.
40. Tate M.D., Brooks A.G., Reading P.C. The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir. Res. 2008, 9:57.
41. Tate M.D., Deng Y.M., Jones J.E., Anderson G.P., Brooks A.G., Reading P.C. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 2009, 183:7441-7450.
42. Tate, M.D., Brooks, A.G., Reading, P.C., 2010a. Inhibition of lectin-mediated innate host defences in vivo modulates disease severity during influenza virus infection. Immunol Cell Bio. In press.
43. Tate M.D., Pickett D.L., van Rooijen N., Brooks A.G., Reading P.C. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J. Virol. 2010, 84:7569-7580.
44. Tate, M.D., Brooks, A.G., Reading, P.C., 2011. Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus. Microb Infect. 13 (2), 202-207.
45. Taylor R.M. Experimental infection with influenza a virus in mice: the increase in intrapulmonary virus after inoculation and the influence of various factors thereon. J. Exp. Med. 1941, 73:43-55.
46. Upham J.P., Pickett D., Irimura T., Anders E.M., Reading P.C. Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J. Virol. 2010, 84:3730-3737.
47. van Eijk M., White M.R., Batenburg J.J., Vaandrager A.B., van Golde L.M., Haagsman H.P., Hartshorn K.L. Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am. J. Respir. Cell Mol. Biol. 2004, 30:871-879.
48. Vigerust D.J., Ulett K.B., Boyd K.L., Madsen J., Hawgood S., McCullers J.A. N-linked glycosylation attenuates H3N2 influenza viruses. J. Virol. 2007, 81:8593-8600.
49. Wagner R., Wolff T., Herwig A., Pleschka S., Klenk H.D. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J. Virol. 2000, 74:6316-6323.
50. Zhang M., Gaschen B., Blay W., Foley B., Haigwood N., Kuiken C., Korber B. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004, 14:1229-1246.